The evolving standards of precision medicine: implications of Tempus abstract findings from the 2022 ASCO® Annual Meeting

Hear panelists Dr. Ezra Cohen of UC San Diego Moores Cancer Center, Dr. Mary J. Fidler of Rush Medical Center and Dr. Wade T. Iams of Vanderbilt-Ingram Cancer Center, discuss which NGS tests should be ordered for optimal patient care. They also delve into various NGS approaches, including the integration of RNA sequencing, concurrent testing using solid tumor and liquid biopsy, and tumor and normal DNA sequencing calculations for TMB.